Prosecution Insights
Last updated: May 29, 2026

Mallinckrodt Pharmaceuticals Ireland Limited

11 pending office actions • 5 art units • 8 examiners • 0 of 11 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Portfolio Summary

11
Total Pending OAs
5
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
3
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 30 days (3)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
6
Medium (55%)
0
Easy (0%)
5
Unknown (45%)

Rejection Statute Mix

BucketCases
§103 only6 (55%)
No statute on record5 (45%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
55% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
45% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEE, JIA-HAI 3 50.1% +48.1%
WEN, SHARON X 2 56.5% +32.8%
TRINH, HONG-VAN N 1 61.7% +59.4%
ZHANG, TINA 1 55.8% +47.3%
DIXON, ANNETTE FREDRICKA 1 74.8% +25.4%
SCOTLAND, REBECCA LYNN 1 0.0% +0.0%
DAHER, KIRA B 1 38.7% +55.3%
STUART, COLIN W 1 58.3% +54.5%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17917209 USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19 SCOTLAND, REBECCA LYNN 54d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18783546 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 222d overdue
17587442 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 59d overdue
19213363 COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME WEN, SHARON X 19d overdue
19169718 PRE-FILLED MANUAL INJECTOR APPARATUS TRINH, HONG-VAN N 9d overdue
18109510 SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC GAS ZHANG, TINA 3d overdue
17007603 Systems And Methods For Providing A Pulse Of A Therapeutic Gas With A Desired Flow Profile To Maximize Therapeutic Effectiveness STUART, COLIN W 2d overdue
17976606 METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME LEE, JIA-HAI 27d
18000188 METHOD FOR PULSATILE DELIVERY OF A GASEOUS DRUG DIXON, ANNETTE FREDRICKA 28d

Top Art Units

Art UnitApps
3785 4
1658 3
1641 2
3783 1
1615 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19213363 COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME WEN, SHARON X 1641 Other Final Rejection 19d overdue Pending May 20, 2025
19169718 PRE-FILLED MANUAL INJECTOR APPARATUS TRINH, HONG-VAN N 3783 §103 Non-Final OA 9d overdue Pending Apr 03, 2025
18783546 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 1658 Other Non-Final OA 222d overdue Pending Jul 25, 2024
18416231 COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME WEN, SHARON X 1641 Other Non-Final OA 30d Pending Jan 18, 2024
18109510 SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC GAS ZHANG, TINA 3785 §103 Non-Final OA 3d overdue Pending Feb 14, 2023
18000188 METHOD FOR PULSATILE DELIVERY OF A GASEOUS DRUG DIXON, ANNETTE FREDRICKA 3785 §103 Final Rejection 28d Pending Nov 29, 2022
17976606 METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME LEE, JIA-HAI 1658 Other Final Rejection 27d Pending Oct 28, 2022
17917209 USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19 SCOTLAND, REBECCA LYNN 1615 §103 Final Rejection 54d Pending Oct 05, 2022
17587442 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 1658 §103 Final Rejection 59d overdue Pending Jan 28, 2022
17420406 USE OF INHALED NITRIC OXIDE (iNO) FOR IMPROVING ACTIVITY LEVELS IN PATIENTS WITH LUNG-RELATED CONDITIONS DAHER, KIRA B 3785 §103 Final Rejection 68d Pending Jul 02, 2021
17007603 Systems And Methods For Providing A Pulse Of A Therapeutic Gas With A Desired Flow Profile To Maximize Therapeutic Effectiveness STUART, COLIN W 3785 Other Non-Final OA 2d overdue Pending Aug 31, 2020

Managing Mallinckrodt Pharmaceuticals Ireland Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month